These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35539642)

  • 21. Potential urinary biomarkers of nephrotoxicity in cyclophosphamide-treated rats investigated by NMR-based metabolic profiling.
    Lim SR; Hyun SH; Lee SG; Kim JY; Kim SH; Park SJ; Moon KS; Sul D; Kim DH; Choi HK
    J Biochem Mol Toxicol; 2017 Mar; 31(3):. PubMed ID: 27870266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism Study on Danggui Shaoyao San and Guizhi Fuling Wan For Treating Primary Dysmenorrheal Based on Biological Network].
    Wang YL; Ru SY; Fang Q; Li GQ; Pan YF; Yao Y; Xu F
    Zhong Yao Cai; 2015 Nov; 38(11):2348-52. PubMed ID: 27356390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An integrative urinary metabolomic study of the therapeutic effect of Guizhi Fuling capsule on primary dysmenorrheal rats based
    Xiong Z; Lang L; Gao X; Xiao W; Wang Z; Zhao L
    J Pharm Biomed Anal; 2019 Feb; 164():750-758. PubMed ID: 30476863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
    Zhu Y; Li Y; Liu M; Hu X; Zhu H
    Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.
    Lu CC; Lin MY; Chen SY; Shen CH; Chen LG; Hsieh HY; Chan MW; Hsu CD
    BMC Complement Altern Med; 2013 Feb; 13():44. PubMed ID: 23433042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model.
    Gao X; Huang C; Geng T; Chen X; Wang J; Liu J; Duan K; Cao L; Wang Z; Xiao W
    J Ethnopharmacol; 2020 Mar; 250():112429. PubMed ID: 31812644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics analysis of Semen Cuscutae protection of kidney deficient model rats using ultra high-performance liquid chromatography-quadrupole time-of-flight Mass Spectrometry.
    Fan RH; Liu CG; Zhang Z; Xing MQ; Han YM; Zhou T; Wang XY; Wang C
    J Pharm Biomed Anal; 2022 Jan; 207():114432. PubMed ID: 34715580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model.
    Lu CC; Shen CH; Chang CB; Hsieh HY; Wu JD; Tseng LH; Hwang DW; Chen SY; Wu SF; Chan MWY; Hsu CD
    Mol Med; 2016 Sep; 22():64-73. PubMed ID: 26837068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring metabolic biomarkers and regulation pathways of acute pancreatitis using ultra-performance liquid chromatography combined with a mass spectrometry-based metabolomics strategy.
    Guo J; Li X; Wang D; Guo Y; Cao T
    RSC Adv; 2019 Apr; 9(21):12162-12173. PubMed ID: 35517037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of disordered metabolic networks in postpartum dairy cows with left displacement of the abomasum through integrated metabolomics and pathway analyses.
    Guo YS; Tao JZ; Xu LH; Wei FH; He SH
    J Vet Med Sci; 2020 Feb; 82(2):115-124. PubMed ID: 31852859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of
    Hao M; Ji D; Li L; Su L; Gu W; Gu L; Wang Q; Lu T; Mao C
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30591632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluate activating blood circulation and dissipating blood stasis effect mechanism of foshousan on acute blood stasis rats on basis of metabolomic approach].
    Huang MY; Tang YP; Li WX; Shang EX; Guo JM; Qian DW; Duan JA
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(20):3576-82. PubMed ID: 24490576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
    Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guizhi-Fuling-Wan, a Traditional Chinese Herbal Medicine, Ameliorates Memory Deficits and Neuronal Apoptosis in the Streptozotocin-Induced Hyperglycemic Rodents via the Decrease of Bax/Bcl2 Ratio and Caspase-3 Expression.
    Wu KJ; Chen YF; Tsai HY; Wu CR; Wood WG
    Evid Based Complement Alternat Med; 2012; 2012():656150. PubMed ID: 23304209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomics analysis of the antidepressant prescription Danzhi Xiaoyao Powder in a rat model of Chronic Unpredictable Mild Stress (CUMS).
    Zhu YL; Li SL; Zhu CY; Wang W; Zuo WF; Qiu XJ
    J Ethnopharmacol; 2020 Oct; 260():112832. PubMed ID: 32387465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary metabolomics of complete Freund's adjuvant-induced hyperalgesia in rats.
    Liu Y; Chen H; Lu J; Jiang Y; Yang R; Gao S; Dong X; Chen W
    Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28058725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
    Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
    Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A UPLC-Q-TOF-MS-based metabolomics approach for the evaluation of fermented mare's milk to koumiss.
    Xia Y; Yu J; Miao W; Shuang Q
    Food Chem; 2020 Aug; 320():126619. PubMed ID: 32203836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
    Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
    J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interactions and biological pathways among metabolomics products of patients with coronary heart disease.
    Chu C; Liu S; Nie L; Hu H; Liu Y; Yang J
    Biomed Pharmacother; 2024 Apr; 173():116305. PubMed ID: 38422653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.